General
Preferred name
Ioflupane I-123
Synonyms
IOFLUPANE I 123 ()
ioflupane ()
Ioflupane (123I) ()
Iodine ioflupane (123i) ()
V09AB03 ()
Striascan ()
Datscan ()
Celsunax ()
(123i)fp-cit ()
Ioflupane, i-123 ()
V-09AB03 ()
Ioflupane (sup 123)i ()
Ioflupane (123l) ()
Fp-cit i-123 ()
Ioflupano (123i) ()
P&D ID
PD046239
CAS
155798-07-5
Tags
drug
Approved by
FDA
EMA
First approval
2011
2000
Drug indication
Movement disorder
Parkinson disease
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
This compound is represented on ChEMBL with slightly different stereochemistry by CHEMBL2096623.
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
9
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
15
Molecular Weight
427.08
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
0
Rotatable Bonds
5
Ring Count
3
Aromatic Ring Count
1
cLogP
3.76
TPSA
29.54
Fraction CSP3
0.61
Chiral centers
4.0
Largest ring
6.0
QED
0.53
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
